The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7‐fold increased risk of polycystic ovary syndrome in a Sardinian population
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
2012 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:77 |
|---|---|
| Enthalten in: |
Clinical endocrinology |
| Beteiligte Personen: |
Capalbo, A. [VerfasserIn] |
|---|
| BKL: |
|---|
| RVK: |
|---|
| Umfang: |
7 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1897413513 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1897413513 | ||
| 003 | DE-627 | ||
| 005 | 20230514120619.0 | ||
| 007 | tu | ||
| 008 | 120608s2012 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw120606_1 |
| 035 | |a (DE-627)OLC1897413513 | ||
| 035 | |a (DE-599)GBVOLC1897413513 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a XA 10000 |q AVZ |2 rvk | ||
| 084 | |a 44.89 |2 bkl | ||
| 084 | |a 44.00 |2 bkl | ||
| 100 | 1 | |a Capalbo, A. |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7‐fold increased risk of polycystic ovary syndrome in a Sardinian population |
| 264 | 1 | |c 2012 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Sagnella, F. |4 oth | |
| 700 | 1 | |a Apa, R. |4 oth | |
| 700 | 1 | |a Fulghesu, A. M. |4 oth | |
| 700 | 1 | |a Lanzone, A. |4 oth | |
| 700 | 1 | |a Morciano, A. |4 oth | |
| 700 | 1 | |a Farcomeni, A. |4 oth | |
| 700 | 1 | |a Gangale, M. F. |4 oth | |
| 700 | 1 | |a Moro, F. |4 oth | |
| 700 | 1 | |a Martinez, D. |4 oth | |
| 700 | 1 | |a Ciardulli, A. |4 oth | |
| 700 | 1 | |a Palla, C. |4 oth | |
| 700 | 1 | |a Uras, M. L. |4 oth | |
| 700 | 1 | |a Spettu, F. |4 oth | |
| 700 | 1 | |a Cappai, A. |4 oth | |
| 700 | 1 | |a Carcassi, C. |4 oth | |
| 700 | 1 | |a Neri, G. |4 oth | |
| 700 | 1 | |a Tiziano, F. D. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical endocrinology <Oxford> |d Oxford [u.a.] : Wiley-Blackwell, 1972 |g 77(2012), 1 vom: Juli, Seite 113-120 |w (DE-627)129299251 |w (DE-600)121745-8 |w (DE-576)014492032 |x 0300-0664 |7 nnns |
| 773 | 1 | 8 | |g volume:77 |g year:2012 |g number:1 |g month:07 |g pages:113-120 |g extent:7 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4219 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 936 | r | v | |a XA 10000 |
| 936 | b | k | |a 44.89 |q AVZ |
| 936 | b | k | |a 44.00 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 77 |j 2012 |e 1 |c 7 |h 113-120 |g 7 | ||